AUBAY (EPA:AUB) | Finanzwire

Basculer en Français

10032	Companies
204164	Keywords
134538	Articles
108308	Press releases

Home
Companies
AUBAY

BRIEF

published on 10/29/2025 at 17:55, 4 months 17 days ago

Strong Growth for Aubay in the Third Quarter of 2025

Revenue Organic Growth France Aubay Solutec
PRESS RELEASE

published on 10/29/2025 at 17:50, 4 months 17 days ago

2025 third-quarter revenue up 24% - Acceleration in organic growth and integration of Solutec - Full-year results forecast sharpened to upper end of the range
Aubay reports strong Q3 2025 revenue growth, boosted by Solutec acquisition and organic growth. France excels; International segment gradually improves. Guidance raised for full year 2025

Revenue Growth Organic Growth Guidance Aubay Q3 2025
BRIEF

published on 10/17/2025 at 07:35, 4 months 30 days ago

Aubay share transactions on October 13 and 14, 2025

Share Buyback Financial Market Aubay Stock Market Transactions Average Stock Price
BRIEF

published on 10/13/2025 at 20:15, 5 months 2 days ago

Aubay: Transactions on Own Shares in October 2025

Actions Stock Market Redemption Aubay October 2025
BRIEF

published on 10/06/2025 at 18:05, 5 months 9 days ago

Aubay: Details of Own Share Transactions as of October 1, 2025

Transactions Share Buyback Own Shares Stock Market Aubay
BRIEF

published on 10/02/2025 at 19:35, 5 months 13 days ago

Declaration of Aubay's voting rights as of September 30, 2025

Voting Rights Financial Markets Capital Distribution Aubay September 2025
BRIEF

published on 09/29/2025 at 17:55, 5 months 16 days ago

Aubay's Transactions on Own Shares in September 2025

Share Buyback Financial Markets Aubay Stock Market Transactions September 2025
BRIEF

published on 09/17/2025 at 18:05, 5 months 28 days ago

AUBAY's 2025 half-year results: stability and prospects for improvement

Financial Results Outlook Operating Margin Aubay Semester 2025
PRESS RELEASE

published on 09/17/2025 at 18:00, 5 months 28 days ago

2025 Half-Yearly Results : First half in line with expectations and impacted by an unfavorable seasonal effect - Annual objectives confirmed
Aubay's Board of Directors approved the H1 2025 financial statements showcasing -1.2% revenue change. Strategic positioning and resilience noted amidst economic uncertainties

Financial Statements Operating Margin Aubay H1 2025 Revenue Change
BRIEF

published on 09/01/2025 at 18:05, 6 months 14 days ago

Declaration of Voting Rights of Aubay as of August 31, 2025

Voting Rights Actions Turnover Aubay Economic Sectors

Accesswire

Published on 03/15/2026 at 23:25, 8 hours 21 minutes ago

Tunkillia 'Phase 2' Resource Upgrade Drilling Begins
Published on 03/15/2026 at 18:00, 13 hours 46 minutes ago

SEG Announced 2025 Annual Results Initiating First Special Dividend Distribution Payout Ratio Reached 88% Newly Signed Orders Exceeded RMB100-Billion Mark for the Second Consecutive Year
Published on 03/13/2026 at 23:00, 2 days 8 hours ago

CORRECTION FROM SOURCE: EV Nickel Announces Maiden Mineral Resource Estimate for Gemini North Nickel Zone
Published on 03/13/2026 at 23:00, 2 days 8 hours ago

Redwood AI Announces Platform Name Change and Appointment of Dr. Mark Dybul as Public Safety & Defense Advisor
Published on 03/13/2026 at 21:30, 2 days 10 hours ago

Alset AI Announces Closing of Shares for Debt Transaction

View all ACCESSWIRE

EQS Group

Published on 03/16/2026 at 07:30, 16 minutes ago

Mutares posts another record year: According to preliminary, unaudited figures, Mutares increases Group revenues and Holding’s net income in the fiscal year 2025 – medium-term targets raised to 25%...
Published on 03/16/2026 at 07:24, 21 minutes ago

EQS-Adhoc: UBS AG: UBS publishes agenda for its Annual General Meeting on 15 April 2026
Published on 03/16/2026 at 07:05, 41 minutes ago

Hypoport delivers solid gross margin growth and disproportionate EBIT increase in 2025
Published on 03/16/2026 at 07:02, 44 minutes ago

Changes to the Board of Directors of Julius Baer Group
Published on 03/16/2026 at 07:00, 46 minutes ago

BioVersys Receives Green Light from US FDA for BV100 HABP/VABP Phase 3 Pivotal Trial Start

Les Echos

Published on 03/13/2026 at 19:50, 2 days 11 hours ago

Availability of ENGIE’S 2025 Universal Registration Document
Published on 03/13/2026 at 18:05, 2 days 13 hours ago

Availability of the 2025 Universal Registration Document of OPmobility SE
Published on 03/13/2026 at 07:30, 3 days ago

BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Published on 03/12/2026 at 18:00, 3 days 13 hours ago

NEW OR RENEWED AGREEMENTS BETWEEN EURAZEO AND CERTAIN FAMILY SHAREHOLDERS
Published on 03/12/2026 at 15:06, 3 days 16 hours ago

FIERA MILANO: THE BOARD OF DIRECTORS APPROVES THE CONSOLIDATED RESULTS AS OF 31 DECEMBER 2025

View all LES ECHOS COMFI WIRE